- Home
- CDXC vs HIPO Comparison
CDXC vs HIPO Comparison
Compare CDXC & HIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXC
- HIPO
- Stock Information
- Founded
- CDXC 1999
- HIPO 2015
- Country
- CDXC United States
- HIPO United States
- Employees
- CDXC N/A
- HIPO N/A
- Industry
- CDXC Medicinal Chemicals and Botanical Products
- HIPO Property-Casualty Insurers
- Sector
- CDXC Health Care
- HIPO Finance
- Exchange
- CDXC Nasdaq
- HIPO Nasdaq
- Market Cap
- CDXC 415.5M
- HIPO 440.1M
- IPO Year
- CDXC N/A
- HIPO N/A
- Fundamental
- Price
- CDXC $5.48
- HIPO $25.61
- Analyst Decision
- CDXC Strong Buy
- HIPO Buy
- Analyst Count
- CDXC 2
- HIPO 3
- Target Price
- CDXC $8.00
- HIPO $28.00
- AVG Volume (30 Days)
- CDXC 587.4K
- HIPO 178.2K
- Earning Date
- CDXC 10-31-2024
- HIPO 11-08-2024
- Dividend Yield
- CDXC N/A
- HIPO N/A
- EPS Growth
- CDXC N/A
- HIPO N/A
- EPS
- CDXC 0.02
- HIPO N/A
- Revenue
- CDXC $91,668,000.00
- HIPO $334,700,000.00
- Revenue This Year
- CDXC $18.64
- HIPO N/A
- Revenue Next Year
- CDXC $20.72
- HIPO $21.75
- P/E Ratio
- CDXC $274.95
- HIPO N/A
- Revenue Growth
- CDXC 9.95
- HIPO 84.92
- 52 Week Low
- CDXC $1.36
- HIPO $7.75
- 52 Week High
- CDXC $7.97
- HIPO $34.24
- Technical
- Relative Strength Index (RSI)
- CDXC 39.30
- HIPO 42.85
- Support Level
- CDXC $5.26
- HIPO $25.98
- Resistance Level
- CDXC $5.56
- HIPO $28.95
- Average True Range (ATR)
- CDXC 0.29
- HIPO 1.65
- MACD
- CDXC -0.09
- HIPO -0.29
- Stochastic Oscillator
- CDXC 18.88
- HIPO 25.55
About CDXC ChromaDex Corporation
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
About HIPO Hippo Holdings Inc.
Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the Company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.